Vital signs: Containment of novel multidrug-resistant organisms and resistance mechanisms - United States, 2006-2017

Morbidity and Mortality Weekly Report

Volumn 67, Issue 13, 2018, Pages 396-401

  Woodworth, Kate Russell ^a   Walters, Maroya Spalding ^a   Weiner, Lindsey M ^a   Edwards, Jonathan ^a   Brown, Allison C ^a   Huang, Jennifer Y ^a   Malik, Sarah ^a   Slayton, Rachel B ^a   Paul, Prabasaj ^a   Capers, Catherine ^a   Kainer, Marion A ^b   Wilde, Nancy ^c   Shugart, Alicia ^a   Mahon, Garrett ^a   Kallen, Alexander J ^a   Patel, Jean ^a   Clifford McDonald, L ^a   Srinivasan, Arjun ^a   Craig, Michael ^a   Cardo, Denise M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c IOWA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE;

DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PUBLIC HEALTH SERVICE; UNITED STATES;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; UNITED STATES;

EID: 85045126711     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6713e1     Document Type: Article

References (11)

1. Weiner L, Webb A, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 2016;37:1288-1301.
2. Jacoby GA, Medeiros AA, O’Brien TF, Pinto ME, Jiang H. Broad-spectrum, transmissible beta-lactamases. N Engl J Med 1988;319:723-4. https://doi.org/10.1056/NEJM198809153191114
3. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-61. https://doi.org/10.1128/AAC.45.4.1151-1161.2001
4. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014;58:697-703. https://doi.org/10.1093/cid/cit795
5. Landman D, Bratu S, Kochar S, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 2007;60:78-82. https://doi.org/10.1093/jac/dkm129
6. CDC. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-60.
7. CDC. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013;62:165-70.
8. CDC. Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/hai/outbreaks/docs/Health-Response-Contain-MDRO.pdf
9. CDC. Antibiotic Resistance Lab Network. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/drugresistance/solutions-initiative/ar-lab-networks.html
10. CDC. New carbapenem-resistant Enterobacteriaceae warrant additional action by healthcare providers; February 14, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. https://stacks.cdc.gov/view/cdc/25250
11. Prabaker K, Lin MY, McNally M, et al.; CDC Prevention Epicenters Program. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012;33:1193-9. https://doi.org/10.1086/668435